Hypoxia and the extracellular matrix: drivers of tumour metastasis
Open accessThe DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Abstract
Of the deaths attributed to cancer, 90% are due to metastasis, and treatments that prevent or cure metastasis remain elusive. Emerging data indicate that hypoxia and the extracellular matrix (ECM) might have crucial roles in metastasis. During tumour evolution, changes in the composition and the overall content of the ECM reflect both its biophysical and biological properties and these strongly influence tumour and stromal cell properties, such as proliferation and motility. Originally thought of as independent contributors to metastatic spread, recent studies have established a direct link between hypoxia and the composition and the organization of the ECM, which suggests a new model in which multiple microenvironmental signals might converge to synergistically influence metastatic outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, secretion of hypoxia-inducible factors (HIFs) by tumor cells induces macrophage and fi broblast recruitment to hypoxic regions of the primary tumor, leading to increased ECM remodeling and angiogenesis [21].”
From 3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions (2021) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In vivo, stromal cells such as fibroblasts and endothelial cells do not remain statically embedded but actively reposition themselves in response to gradients in oxygen, nutrients, and soluble factors [274,275].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [274]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“recently published literature discusses the role of the size of a tumor (and the associated hypoxia levels) on its aggressiveness [81,82,83,84,85] and on the efficacy of drug delivery to it [84,86,87].”
From The Tumor-on-Chip: Recent Advances in the Development of Microfluidic Systems to Recapitulate the Physiology of Solid Tumors (2019) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedGilkes, D. M., Bajpai, S., Chaturvedi, P., Wirtz, D., & Semenza, G. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442939 · Cited by 467
Self-citationRetractedZhang, H., Wong, C. C. L., Wei, H., Gilkes, D. M., Korangath, P., Chaturvedi, P., Schito, L., Chen, J., Krishnamachary, B., Winnard, P. T., et al. (2012) · Oncogene · doi:10.1038/onc.2011.365 · Cited by 326
Self-citationRetractedRETRACTED: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis
Gilkes, D. M., Chaturvedi, P., Bajpai, S., Wong, C. C., Wei, H., Pitcairn, S., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3963 · Cited by 296
Self-citationRetractedProcollagen lysyl hydroxylase 2 is essential for hypoxia-induced breast cancer metastasis
Gilkes, D. M., Bajpai, S., Wong, C. C., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0629 · Cited by 252
Self-citationRetractedGilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184
Self-citationRetractedMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Self-citationWang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Cited by
Items 301–400 of 1,001
Yoo, J., Seo, B. K., Park, E. K., Kwon, M., Jeong, H., Cho, K. R., Woo, O. H., Song, S. E., & Cha, J. (2020) · Cancer Imaging · doi:10.1186/s40644-020-00362-7 · Cited by 67
“Production of collagen and increased collagen crosslinking in the ECM, of which collagen is a major component, in the hypoxic tumor microenvironment promote tumor stiffness, encourage tumor cell dissemination, and induce drug resistance [2, 14, 15, 18, 19, 38].”
BackgroundMechanisms of Cisplatin Resistance in HPV Negative Head and Neck Squamous Cell Carcinomas
Griso-Acevedo, A. B., Acero-Riaguas, L., Castelo, B., Carretero, J. L. C., & Sastre-Perona, A. (2022) · Cells · doi:10.3390/cells11030561 · Cited by 73
A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent
Gioelli, N., Maione, F., Camillo, C., Ghitti, M., Valdembri, D., Morello, N., Darche, M., Zentilin, L., Cagnoni, G., Qiu, Y., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aah4807 · Cited by 59
Multistage vector (MSV) therapeutics
Wolfram, J., Shen, H., & Mauro Ferrari, B. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.010 · Cited by 60
Xu, X., Gong, X., Wang, Y., Li, J., Wang, H., Wang, J., Sha, X., Li, Y., & Zhang, Z. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900181 · Cited by 60
Zhang, X., Zhao, Q. C., Yang, J., Wang, T., Chen, F., & Zhang, K. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215115 · Cited by 60
A proteogenomics data-driven knowledge base of human cancer
Liao, Y., Savage, S. R., Dou, Y., Shi, Z., Yi, X., Jiang, W., Lei, J. T., & Zhang, B. (2023) · Cell Systems · doi:10.1016/j.cels.2023.07.007 · Cited by 67
Prospective observational study on biomarkers of response in pancreatic ductal adenocarcinoma
Jiang, L., Qin, J., Dai, Y., Zhao, S., Zhan, Q., Cui, P., Ren, L., Wang, X., Zhang, R., Gao, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02790-x · Cited by 65
“These findings support the clinical relevance of the functional protein modules, with hypoxia and ECM organization potentially explaining the metastatic spread of tumor cells 29 .”
Jing, S., Wang, H.-Q., Lin, P., Yuan, J., Tang, Z., & Li, H. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00857-1 · Cited by 79
“Notably, hypoxia is usually caused by the rapid proliferation of cancer cells, coupled with abnormal structure and function of tumor blood vessels, which reduces the oxygen supply to certain areas within solid tumors 155 (Fig.”
Newly developed gas-assisted sonodynamic therapy in cancer treatment
Pan, M., Hu, D., Yuan, L., Yu, Y., Li, Y., & Qian, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.021 · Cited by 59
Poison cassette exon splicing ofSRSF6regulates nuclear speckle dispersal and the response to hypoxia
Machado, C. D. O. F., Schafranek, M., Brüggemann, M., Cañás, M. C. H., Keller, M., Liddo, A. D., Brezski, A., Blümel, N., Arnold, B., Bremm, A., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1225 · Cited by 63
Clinical and prognostic value of the C‐Met/HGF signaling pathway in cervical cancer
Boromand, N., Hasanzadeh, M., Shahidsales, S., Farazestanian, M., Gharib, M., Fiuji, H., Behboodi, N., Ghobadi, N., Hassanian, S. M., Ferns, G. A., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26232 · Cited by 55
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 63
Cartilage Lacuna‐Inspired Microcarriers Drive Hyaline Neocartilage Regeneration
Ding, S., Zhao, X., Xiong, W., Ji, L., Jia, M., Liu, Y., Guo, H., Qu, F., Cui, W., Gu, Q., et al. (2023) · Advanced Materials · doi:10.1002/adma.202212114 · Cited by 56
Extracellular vesicle-mediated pre-metastatic niche formation via altering host microenvironments
Li, Y., Zheng, Y., Tan, X., Du, Y., Wei, Y., & Liu, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1367373 · Cited by 74
Molecular imaging of hypoxia in non-small-cell lung cancer
Yip, C., Blower, P. J., Goh, V., Landau, D., & Cook, G. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3009-6 · Cited by 58
Yin, J., Lang, T., Cun, D., Zheng, Z., Huang, Y. L., Yin, Q., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.21516 · Cited by 57
Yuan, S., Xiang, Y., Wang, G., Zhou, M., Meng, G., Liu, Q., Hu, Z., Li, C., Xie, W., Wu, N., et al. (2019) · Molecular Oncology · doi:10.1002/1878-0261.12437 · Cited by 62
Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity
Lucchetti, D., Tenore, C. R., Colella, F., & Sgambato, A. (2020) · Cancers · doi:10.3390/cancers12010171 · Cited by 61
“Much evidence has shown that cancer cells adapt to a hypoxic microenvironment for their survival [97].”
BackgroundSun, J., Zhao, T., Zhao, D., Qi, X., Bao, X., Shi, R., & Su, C. (2020) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835920937904 · Cited by 63
Lu, F., Ye, M., Shen, Y., Xu, Y., Hu, C., Chen, J., Yu, P., Xue, B., Gu, D., Xu, L., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.96831 · Cited by 55
Tawk, B., Schwager, C., Deffaa, O. J., Dyckhoff, G., Warta, R., Linge, A., Krause, M., Weichert, W., Baumann, M. A., Herold‐Mende, C. C., et al. (2015) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2015.11.027 · Cited by 60
Targeted Polymeric Nanoparticles for Drug Delivery to Hypoxic, Triple-Negative Breast Tumors
Mamnoon, B., Loganathan, J., Confeld, M. I., Fonseka, N. D., Feng, L., Froberg, J., Choi, Y., Tuvin, D. M., Sathish, V., & Mallik, S. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c01336 · Cited by 59
Shou, Y., Teo, X. Y., Li, X., Le, Z., Liu, L., Sun, X., Jonhson, W., Ding, J., Lim, C. T., & Tay, A. K. P. (2023) · ACS Nano · doi:10.1021/acsnano.2c11278 · Cited by 56
Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs
Yeh, J. J., & Kim, W. Y. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.0759 · Cited by 61
PEG-Chitosan Hydrogel with Tunable Stiffness for Study of Drug Response of Breast Cancer Cells
Chang, F., Tsao, C.-T., Lin, A., Zhang, M., Levengood, S., & Zhang, M. (2016) · Polymers · doi:10.3390/polym8040112 · Cited by 56
The critical role of microRNAs in stress response: Therapeutic prospect and limitation
Du, J., Li, M., Huang, Q., Liu, W., Li, W., Li, Y., & Gong, Z. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.007 · Cited by 58
Gonzalez‐Molina, J., Moyano‐Galceran, L., Single, A., Gultekin, O., Alsalhi, S., & Lehti, K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.012 · Cited by 59
Koens, R., Tabata, Y., Serrano, J. C., Aratake, S., Yoshino, D., Kamm, R. D., & Funamoto, K. (2020) · APL Bioengineering · doi:10.1063/1.5127069 · Cited by 53
Jana, A., Nookaew, I., Singh, J., Behkam, B., Franco, A. T., & Nain, A. S. (2019) · The FASEB Journal · doi:10.1096/fj.201900131r · Cited by 54
Yan, Y., Chen, B., Yin, Q., Wang, Z., Yang, Y., Wan, F., Wang, Y., Tang, M., Xia, H., Chen, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29679-6 · Cited by 55
Luthold, C., Hallal, T., Labbé, D. P., & Bordeleau, F. (2022) · Cancers · doi:10.3390/cancers14122887 · Cited by 66
Peng, W., Xiong, E., Ge, L., Wan, Y.-Y., Zhang, C., Du, F., Xu, M., Bhat, R. A., Jin, J., & Gong, A. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.12.006 · Cited by 54
Targeting P4HA1 with a Small Molecule Inhibitor in a Colorectal Cancer PDX Model
Agarwal, S., Behring, M. P., Kim, H., Bajpai, P., Chakravarthi, B. V. S. K., Gupta, N., Elkholy, A., Diffalha, S. A., Varambally, S., & Manne, U. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100754 · Cited by 57
“Synthesis, deposition, and degradation of the ECM promote cancer progression and metastasis [39].”
BackgroundLuan, N., Mu, Y., Mu, J., Chen, Y., Ye, X., Zhou, Q., Xu, M., Deng, Q., Hu, Y., Tang, Z., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.638244 · Cited by 54
Ansardamavandi, A., & Tafazzoli‐Shadpour, M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119103 · Cited by 57
Correlation between the Warburg effect and progression of triple-negative breast cancer
Liu, S., Li, Y., Yuan, M., Song, Q., & Liu, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1060495 · Cited by 61
Sheng, Y., Ren, Q., Tao, C., Wen, M., Qu, P., Yu, N., Li, M., Chen, Z., & Xie, X. (2023) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2023.04.092 · Cited by 52
Hypoxia promotes Rab5 activation, leading to tumor cell migration, invasion and metastasis
Silva, P., Mendoza, P., Rivas, S., Díaz, J., Moraga, C. V., Quest, A. F. G., & Torres, V. A. (2016) · Oncotarget · doi:10.18632/oncotarget.8794 · Cited by 55
P4HA2 contributes to cervical cancer progression via inducing epithelial-mesenchymal transition
Cao, Y., Han, Q., Li, J., Jia, Y., Zhang, R., & Shi, H. (2020) · Journal of Cancer · doi:10.7150/jca.38401 · Cited by 53
“Previous report demonstrated that hypoxia could promote the cancer invasion process by regulating collagen biosynthesis and deposition[26].”
BackgroundHypoxia Onset in Mesenchymal Stem Cell Spheroids: Monitoring With Hypoxia Reporter Cells
Schmitz, C., Potekhina, E. S., Irianto, T., Belousov, V. V., & Lavrentieva, A. V. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.611837 · Cited by 62
el Maaty, M. A. A., Terzic, J., Keime, C., Rovito, D., Lutzing, R., Yanushko, D., Parisotto, M., Grelet, É., Namer, I. J., Lindner, V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2295 · Cited by 56
Ziegler, Y. S., Moresco, J. J., Yates, J. R., & Nardulli, A. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158296 · Cited by 51
Real-time imaging of cancer cell chemotaxis in paper-based scaffolds
Kenney, R. M., Boyce, M. W., Truong, A. S., Bagnell, C. R., & Lockett, M. R. (2015) · The Analyst · doi:10.1039/c5an01787d · Cited by 58
Park, S., Safi, R., Liu, X., Baldi, R., Liu, W., Liu, J., Locasale, J. W., Chang, C.-Y., & McDonnell, D. P. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.066 · Cited by 51
Xiao, X., Chen, M., Zhang, Y., Li, L., Peng, Y., Li, J., & Zhou, W. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01617-0 · Cited by 55
“One typical pathological feature of tumor is hypoxia [7], which completely mismatches the basic requirement of PDT.”
BackgroundFluid flow to mimic organ function in 3D in vitro models
Juste-Lanas, Y., Hervás-Raluy, S., García‐Aznar, J. M., & González‐Loyola, A. (2023) · APL Bioengineering · doi:10.1063/5.0146000 · Cited by 55
Akinjiyan, F. A., Ibitoye, Z., Zhao, P., Shriver, L. P., Patti, G. J., Longmore, G. D., & Fuh, K. C. (2023) · Oncogene · doi:10.1038/s41388-023-02884-3 · Cited by 58
“Their abundance, fi ber orientation, and architecture have been shown to be associated with pro-tumorigenesis in multiple cancers [1 – 8].”
Multiple aspects of matrix stiffness in cancer progression
Mancini, A., Gentile, M. T., Pentimalli, F., Cortellino, S., Grieco, M., & Giordano, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1406644 · Cited by 61
“In particular, LOX expression is upregulated in many tumors, for example mesothelioma, downstream of hypoxia (HIFs) by a mechanism that is, in part, driven by TGF b (22, 85, 86).”
Backgroundda Cunha, C. B., Klumpers, D. D., Koshy, S. T., Weaver, J. C., Chaudhuri, O., Seruca, R., Carneiro, F., Granja, P. L., & Mooney, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.04.016 · Cited by 52
Endo, H., Okami, J., Okuyama, H., Nishizawa, Y., Imamura, F., & Inoue, M. (2017) · Oncogene · doi:10.1038/onc.2016.431 · Cited by 50
The Biophysics of 3D Cell Migration
Wu, P.-H., Gilkes, D. M., & Wirtz, D. (2018) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-070816-033854 · Cited by 55
Self-citationStimulus-responsive gold nanotheranostic platforms for targeting the tumor microenvironment
Jin, J., Ovais, M., & Chen, C. (2018) · Nano Today · doi:10.1016/j.nantod.2018.08.007 · Cited by 52
Proinvasive extracellular matrix remodeling for tumor progression
Kaushik, N., Kim, S., Suh, Y., & Lee, S. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1097-0 · Cited by 53
Irvine, A. F., Waise, S., Green, E. W., Stuart, B. L., & Thomas, G. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81796-2 · Cited by 55
Zhao, Y., Liu, G., Sun, Q., Zhai, G., Wu, G., & Li, Z. (2021) · European Radiology · doi:10.1007/s00330-020-07590-2 · Cited by 51
“Among the four pathways, the most significantly enriched pathway, ECM-receptor interaction, plays an important part in tumor cell maintenance [30], where interactions between tumor cells and ECM lead to a direct or indirect control of tumor cellular activities such as adhesion, migration, differentiation, proliferatio…”
BackgroundLi, Z., Shi, J., Zhang, N., Zheng, X., Jin, Y., Wen, S., Hu, W., Wu, Y., & Gao, W. (2022) · Journal of Cancer · doi:10.7150/jca.67977 · Cited by 51
“It is the result of excessive tumor growth and insufficient blood supply, which play a central role in tumor metastasis [80-82].”
BackgroundRedox balance and autophagy regulation in cancer progression and their therapeutic perspective
Khan, S. U., Fatima, K., Aisha, S., Hamza, B., & Malik, F. A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01871-0 · Cited by 61
Yang, S., Zhang, D., Sun, Q., Nie, H., Zhang, Y., Wang, X., Huang, Y., & Sun, Y. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3264 · Cited by 68
Harnessing Hypoxia‐Dependent Cyanine Photocages for In Vivo Precision Drug Release
Zhang, Y., Yan, C., Zheng, Q., Jia, Q., Wang, Z., Shi, P., & Guo, Z. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202017349 · Cited by 52
Wang, S., Tan, W., Lang, W., Qian, H., Guo, S., Zhu, L., & Ge, J. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00512 · Cited by 50
Li, X., Wu, Y., Zhang, R., Bai, W., Ye, T., & Wang, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.683519 · Cited by 60
Gong, P., Wang, F., Hua, Y., Ying, J., Chen, J., & Qiao, Y. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03815-y · Cited by 65
“…tissue hypoxia, and hypoxia-induced acidosis would in turn enhance the activity of lysyl oxidase (LOX) family to catalyzes aberrant collagen cross-linking, as well as the release of pro-invasive factors such as TGF-β , which establishes a self-reinforcing “fibrosis-acidification” loop [159–161].”
Validation of a hypoxia related gene signature in multiple soft tissue sarcoma cohorts
Yang, L., Forker, L. J., Irlam, J. J., Pillay, N., Choudhury, A., & West, C. (2017) · Oncotarget · doi:10.18632/oncotarget.23280 · Cited by 51
Natale, B. V., Mehta, P., Vu, P., Schweitzer, C. L., Gustin, K., Kotadia, R., & Natale, D. R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35606-x · Cited by 55
Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3–c-Myc axis
Gao, Q., Zhou, R., Meng, Y., Duan, R., Wu, L., Li, R., Deng, F., Lin, C., & Zhao, L. (2020) · Oncogene · doi:10.1038/s41388-020-1266-8 · Cited by 52
Gui, C., Wei, J., Chen, Y., Fu, L., Tang, Y., Cao, J., Chen, W., & Luo, J. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab173 · Cited by 46
Feng, S., Xia, T., Ge, Y. P., Zhang, K., Ji, X., Luo, S., & Shen, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.868067 · Cited by 52
“The hypoxic microenvironment regulates carcinogenesis, radiotherapy, and chemotherapy resistance (6).”
BackgroundHMGA1 induces FGF19 to drive pancreatic carcinogenesis and stroma formation
Chia, L., Wang, B., Kim, J., Luo, L., Shuai, S., Herrera, I., Chen, S. Y., Li, L., Xian, L., Huso, T. H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci151601 · Cited by 57
“Similarly, biomechanical analyses suggest that a “stiff” tumor microenvironment alters tumor cells to enhance motility and facilitate metastases (13–15).”
Ma, X., Liang, X., Yao, M., Gao, Y., Luo, Q., Li, X., Yu, Y., Sun, Y., Cheng, M. H. Y., Chen, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41782-w · Cited by 49
“As a hostile hallmark, tumor hypoxiais related to poor prognosis, tumor metastasis and resistance to various treatments 23,31 .”
PAI‐1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma
Peterle, G. T., Maia, L. L., Trivilin, L. O., de Oliveira, M. M., dos Santos, J. G., Mendes, S. O., Stur, E., Agostini, L. P., Rocha, L. A., Moysés, R. A., et al. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12721 · Cited by 62
“Turn‐On” Activatable AIE Dots for Tumor Hypoxia Imaging
Xue, T., Jia, X., Wang, J., Xiang, J., Wang, W., Du, J., & He, Y. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201902296 · Cited by 47
Luteolin impairs hypoxia adaptation and progression in human breast and colon cancer cells
Monti, E., Marras, E., Prini, P., & Gariboldi, M. B. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173210 · Cited by 48
Plasma medicine: Opportunities for nanotechnology in a digital age
Liu, D., Szili, E. J., & Ostrikov, K. (2020) · Plasma Processes and Polymers · doi:10.1002/ppap.202000097 · Cited by 47
Liu, Y., He, D., Xiao, M., Zhu, Y., Zhou, J., & Cao, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03523-z · Cited by 49
Wang, L., Dou, J., Jiang, W., Wang, Q., Liu, Y., Liu, H., & Wang, Y. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c01005 · Cited by 49
Yang, Y., Zeng, Z., Almatrafi, E., Huang, D., Zhang, C., Xiong, W., Cheng, M., Zhou, C., Wang, W., Song, B., et al. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214427 · Cited by 50
Immune evasion in esophageal squamous cell cancer: From the perspective of tumor microenvironment
Li, R., Huang, B. Q., Tian, H., & Sun, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1096717 · Cited by 57
Kang, H., Strong, A. L., Sun, Y., Guo, L., Juan, C., Bancroft, A. C., Choi, J. H., Pagani, C. A., Fernandes, A. A., Woodard, M., et al. (2024) · Bone Research · doi:10.1038/s41413-024-00320-0 · Cited by 52
“25,26 Collagen lysyl hydroxylase 2 (PLOD2), an essential collagen-modifying enzyme 12,27,28 that affects cross-linking by LOX family enzymes of type I and III collagens (the primary collagens at HO sites), 29,30 is induced upon exposure to hypoxia in a HIF-1 α , not HIF-2 α , dependent manner.”
Background3D Cell Cultures as Prospective Models to Study Extracellular Vesicles in Cancer
Bordanaba-Florit, G., Madarieta, I., Olalde, B., Falcón‐Pérez, J. M., & Royo, F. (2021) · Cancers · doi:10.3390/cancers13020307 · Cited by 49
“Greater understandings of tumor microenvironment have identified ECM to play critical roles in orchestrating drug resistance, disease progression and tumor metastasis [32].”
BackgroundSmart and bioinspired systems for overcoming biological barriers and enhancing disease theranostics
Li, X., Gao, Y., Li, H., Majoral, J., Shi, X., & Pich, A. (2023) · Progress in Materials Science · doi:10.1016/j.pmatsci.2023.101170 · Cited by 48
Pei, J., Zhang, C., Yusupu, M., Zhang, C., & Dai, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.705511 · Cited by 52
HIF-1α promotes the migration and invasion of cancer-associated fibroblasts by miR-210
Yang, Y., Gu, J., Li, X., Xue, C., Ba, L., Gao, Y., Zhou, J., Bai, C., Sun, Z., & Zhao, R. C. (2021) · Aging and Disease · doi:10.14336/ad.2021.0315 · Cited by 50
“Hypoxia induced HIF-1α expression in tumor cells, followed by metabolic reprogramming, angiogenesis, stromal remodeling, and migration and invasion enhancement [37].”
Tumor-associated fibrosis impairs the response to immunotherapy
Naik, A., & Leask, A. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.04.002 · Cited by 49
Qiu, C., Wang, W., Xu, S., Li, Y., Zhu, J., Zhang, Y., Lei, C., Li, W., Li, H., & Li, X. (2024) · BMC Cancer · doi:10.1186/s12885-024-12182-0 · Cited by 49
“As a marker of TME, hypoxia was involved in various aspects of tumor progression [9, 27–28].”
BackgroundPhagocyte—extracellular matrix crosstalk empowers tumor development and dissemination
Varol, C., & Sagi, I. (2017) · FEBS Journal · doi:10.1111/febs.14317 · Cited by 50
Deng, L., Feng, Z., Deng, H., Jiang, Y., Song, K., Shi, Y., Liu, S., Zhang, J., Bai, S., Qin, Z., et al. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12129 · Cited by 45
Wang, X., Li, C., Jin, H., Wang, X., Ding, C., Cao, D., Zhao, L., Deng, G., Lü, J., Wan, Z., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.134438 · Cited by 45
Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types
Izzi, V., Lakkala, J., Devarajan, R., Kääriäinen, A., Koivunen, J. T., Heljäsvaara, R., & Pihlajaniemi, T. A. (2019) · Matrix Biology Plus · doi:10.1016/j.mbplus.2019.04.001 · Cited by 42
Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression
Wang, M., Lan, S., Zhang, W., Jin, Q., Du, H., Sun, X., He, L., Meng, X., Su, L., & Liu, G. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s449887 · Cited by 47
“16,17 18–22 Moreover, the alterations in oncogenes or tumor suppressors such as tumor suppressor p53 (TP53) or hypoxia-inducible factor 1 (HIF-1) also disturbed mitochondrial respiration and cellular metabolism, in turn contributing to enhanced tumorigenesis and carcinogenic transformation, as well…”
BackgroundA 3D-Printed Oxygen Control Insert for a 24-Well Plate
Brennan, M., Rexius‐Hall, M. L., & Eddington, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137631 · Cited by 48
Zhang, L., Xiong, W., Li, N., Liu, H., He, H., Du, Y., Zhang, Z., & Liu, Y. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.11.008 · Cited by 50
Network analysis of EMT and MET micro-RNA regulation in breast cancer
Garcia, D. D., Enríquez, J. E., & Lemus, E. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-13903-1 · Cited by 47
Cancer-derived extracellular vesicles: friend and foe of tumour immunosurveillance
Dörsam, B., Reiners, K. S., & von Strandmann, E. P. (2018) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0481 · Cited by 44
Hypoxia re-programs 2′-O-Me modifications on ribosomal RNA
Metge, B. J., Kammerud, S. C., Pruitt, H. C., Shevde, L. A., & Samant, R. S. (2020) · iScience · doi:10.1016/j.isci.2020.102010 · Cited by 54
“It is one of the noticeable features of solid tumors and is a critical determinant of tumor progression (Gilkes et al., 2014; Nakazawa et al., 2016).”
BackgroundJiang, Z. L., He, L., Yu, X., Yang, Z., Wu, W., Wang, X., Mao, R., Cui, D., Chen, X. S., & Li, W. (2021) · ACS Nano · doi:10.1021/acsnano.1c01063 · Cited by 44
Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance
Popovic, A., & Tartare‐Deckert, S. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.924553 · Cited by 50
Yu, H., Zhuang, J., Zhou, Z., Song, Q., Lv, J., Yang, X. F., Yang, H., & Lü, Q. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.86719 · Cited by 51
“In fact, hypoxia is a known poor prognosis marker, driving therapy resistance[41, 42], angiogenesis[43, 44], metastasis[45, 46] and tumor progression[47, 48].”
Mechanobiology of Cancer Stem Cells and Their Niche
Choudhury, A. R., Gupta, S., Chaturvedi, P. K., Kumar, N., & Pandey, D. (2019) · Cancer Microenvironment · doi:10.1007/s12307-019-00222-4 · Cited by 48
Organic Nanocarriers for Delivery and Targeting of Therapeutic Agents for Cancer Treatment
Peng, Y., Bariwal, J. B., Kumar, V., Tan, C., & Mahato, R. I. (2020) · Advanced Therapeutics · doi:10.1002/adtp.201900136 · Cited by 46
Metadata
- Authors
- Gilkes, D. M., Semenza, G. L., & Wirtz, D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Wirtz, Denis
- Venue
- Nature Reviews Cancer
- Published
- 2014-05-15
- Volume
- 14
- Issue
- 6
- Pages
- 430-439
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC4283800
- OpenAlex
- W2069518226
- Cited by
- 1,520
- References
- 209
- Citations by year
- 2026: 99 · 2025: 129 · 2024: 149 · 2023: 151 · 2022: 175 · 2021: 192 · 2020: 164 · 2019: 132 · 2018: 106 · 2017: 95 · 2016: 75 · 2015: 41 · 2014: 9
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (U54CA143868, R01CA174388, K99CA181352)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- tumor hypoxia, extracellular matrix, tumour metastasis, tumor microenvironment, stromal cells, tumor cell motility, tumor cell proliferation
- MeSH terms
- Hypoxia, Extracellular Matrix, Humans, Neoplasm Metastasis, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.